US-headquartered pharmaceutical company Pfizer has opened a new £7m cold storage facility at its site in Havant, Hampshire, UK.
The new facility that specialises in cold chain packaging and supply is the latest addition to over £42m worth of investment made at the site since 2008.
The facility, which also has also a new high-speed vaccines packaging line, provides temperature sensitive vaccines and injectable medicines to over 120 destinations around the world.
Pfizer claims that the cold storage facility can store up to 38.4 million doses of temperature sensitive vaccines and medicines, which from there are distributed to clinicians and patients.
The company’s Havant site lead Jon Tucker said the site is recognised as a centre of excellence for cold chain distribution and packaging and features a team that has developed leading supply and logistics technologies.
In October 2010, Pfizer already opened a new £26.3m biotechnology packaging facility in Hampshire, UK.
Havant is a major hub for Pfizer and its group company Wyeth, which was acquired and merged in 2009.
The site has been used for the packaging and distribution of some of the company’s biologic drugs and vaccines including Enbrel and vaccine products such as Prevnar/Prevenar.